Based in GREENWICH, CT, THE FIBROLAMELLAR CANCER FOUNDATION operates as a Public Charity. The organization reported $3.4M in revenue, $2.9M in expenses, $10.2M in total assets for fiscal year 2024. Imperigo tracks 62 reported grant relationships connected to this organization totaling approximately $3.0M.
FIBROLAMELLAR CANCER FOUNDATION,(THE "FOUNDATION") WAS ESTABLISHED TO RAISE AWARENESS AND RESEARCH FUNDS FOR FIBROLAMELLAR CARCINOMA, A RARE FORM OF LIVER CANCER THAT IS PRIMARILY SEEN IN TEENS AND YOUNG ADULTS. CURRENTLY, THERE ARE NO VIABLE TREATMENT OPTIONS OTHER THAN LIVER RESECTION SURGERY. OUR MISSION IS TO FIND A CURE AND RELIABLE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH THIS RARE DISEASE AS WELL AS ENHANCE COMMUNICATIONS AMONG HEALTHCARE PROFESSIONALS AND PATIENTS.
How The Fibrolamellar Cancer Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Showing up to 5 of 62 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $3.4M | $2.9M | $10.2M |
| 2023 | $3.0M | $5.5M | $10.5M |
| 2022 | $6.1M | $2.6M | $11.0M |
| 2020 | $1.8M | $2.7M | $5.4M |
| 2019 | $1.8M | $1.8M | $5.0M |
Between 2019 and 2024, reported annual revenue grew from $1.8M to $3.4M (+93%), with total assets most recently reported at $10.2M.
Interactive year-over-year charts and full filing details available with membership.
